contrasuppression by W adherent T8 cells (Lehner et al. 1984 ). Antibodies to human class II molecules are similarly inhibiting. Whether these I-J like molecules are analogous to their murine counterpart is unknown. It is possible that they act to focus antigen for recognition by the T4-positive helper cells.
Despite the enormous progress being made concerning the nature of T cell receptors, a number of fundamental questions remain unanswered. For example, are the antigen-recognition products on T cell factors similar to the V region products used for the Tr? The finding that factors bind to nominal antigen alone whilst the functional cells, at least for Th and Tc, recognize neither antigen nor histocompatibility molecules in isolation seems to argue against this. It may be that factors make use of different V region sequences of the Tr genes. The question of what genes form the basis of specificity for Ts or contrasuppressor cells is unresolved, as are which parts of the Tra or fi chains bind to antigen or MHC product. New Extracorporeal shockwave lithotripsy'
The Lithotripter Centre at the Devonshire Hospital, London, was the venue for the meeting held by the Section of Urology on 28 March 1985 to discuss the recent advances of extracorporeal shockwave lithotripsy (ESWL) and percutaneous renal stone surgery; the meeting was chaired by Mr J E A Wickham. Professor F Eisenberger of Stuttgart, one of the principal architects of ESWL, described the evolution and development of the technique to its present state. Shockwaves were first investigated by the Dornier company after damage to the canopies of supersonic jet aircrafts. A capacitor was produced to create these shockwaves and a focusing device using an elliptical reflector devised to precisely concentrate the shockwaves. The first stage of development was to establish that shockwaves did not harm biological tissues. In vitro studies on all blood elements, bone marrow, body tissue and eventrated organs showed no damage except when directly focused on lung tissue containing air. In vitro stone destruction confirmed that all varieties of renal stones could be fragmented. Experiments on implanted human calculi in the renal pelvis of Journal ofthe Royal Society ofMedicine Volume 78 December 1985 1063 dogs confirmed the safety of ESWL. Ultrasound, the initial method of stone localization, was discovered to be inappropriate because of its inability to resolve fine calculus fragments. Biplanar X-ray fluoroscopy was developed as a successful alternative. In the 1980 Chaussy et al. reported the first clinical series of patients treated by ESWL.
Professor Eisenberger outlined the progress of clinical treatment from small easy stones to the complicated staghorn. Stones that are opaque, not large and in an unobstructed urinary system are suitable for treatment by ESWL. The major contraindications include coagulation disorders or inability radiologically to localize the stone due to poor opacity or obesity. Some smaller lucent stones can be treated effectively with the assistance of contrast. In very obese patients, the stone cannot be positioned within the focal distance (20 cm) of the shockwave focus. The Stuttgart experience has shown that the incidence of complications following ESWL of colic, pain, fevers and ureteric obstruction is less than 6% for stones with a diameter of less than 2 cm. However, as stones increase in size, these complications rise to over 30%. To treat large stones percutaneous nephrolithotomy (PCN) is performed prior to ESWL. This reduces the major stone bulk and provides a nephrostomy track which acts to prevent obstruction and also offers an alternative conduit to the ureter for the subsequent stone particle exit. Using a combination of these procedures, the incidence of open stone surgery has been reduced to less than 2% in Stuttgart.
At 3 months' follow up after ESWL, 85% of patients are completely free of stone particles. Of the remaining 15%, 11% will pass their fragments spontaneously and the remainder will require a second treatment by ESWL. PCN or ureterorenal surgery (URS). Postoperative long-and shortterm investigations by renography, ultrasound, computed tomography and creatinine clearance have shown no significant damage to the kidneys or surrounding organs.
The anaesthetic presentation by Dr M A Abbott dealt with patient selection and the safety precautions required during anaesthesia for ESWL, rather than with the minutiae of the actual technique used. Patient selection is divided into two sections: the physically fit and unfit. The first group can be offered their treatment under a general anaesthetic or with epidural analgesia with sedation. The advantage of regional anaesthesia includes a rapid recovery with minimal constitutional upset combined with superior postoperative analgesia. If severe postoperative pain due to the passage of large 'sand masses' is expected or secondary procedures are to be undertaken, the epidural catheter can be left in situ and used to good effect. The problems associated with tracheal intubation are also avoided. Contraindications to the epidural technique are previous spinal surgery or pathology, demyelinating disease, diabetic autonomic neuropathy, and the patient's expressed aversion to the technique.
Patients with cardiovascular and gross respiratory disease are better treated with a general anaesthetic. A chronic cough can lead to difficulties in positioning the renal calculus and maintaining it at the secondary focus. The act of coughing can expose lung to the shockwaves and precipitate haemoptysis. Acute bronchospasm in the unstable asthmatic is more difficult to treat in the awake patient. Untreated moderate hypertensives and those who require aggressive treatment to maintain control are prone to severe swings in blood pressure, especially hypotension. The left-and right-sided cardiac preloads rise quite dramatically on immersion. A slow rate of immersion is recommended for those with myocardial insufficiency or valvular disease. Inotropes and vasodilators may be required in the severely affected.
A radiograph was presented which showed the spread of air used in the location of the epidural space. It could be seen tracking down from the epidural space and along the lumbar plexus. Damage to the spinal cord or nerves could occur at tissue/ air interfaces. The use of saline in the 'loss of resistance' technique is considered mandatory.
In conclusion, the avoidance of clinical problems through the frequent use of patient monitoring was highlighted. An automatic blood pressure monitor is advantageous in view of the head-up position during treatment and the tendency towards hypotension, as is a ventilator alarm or guard against accidental disconnection, especially during X-ray screening. Fixation of the ECG electrodes on the arms and forehead will keep them dry and ensure a good signal to the ESWL triggering mechanism.
The London experience of ESWL was presented by Mr D R Webb who described the initial difficulties and pitfalls of such a new procedure with no obvious precedent. An analysis of the first 100 cases was presented. The most striking clinical features were the lack of patient morbidity and short inpatient stay and convalescence. Half required no analgesia following ESWL, 16% required parenteral analgesia for up to 48 hours, and the remainder oral analgesia. The average inpatient stay was 3.7 days, with most, patients returning to work within a few days of discharge. Since commencing ESWL, the change in clinical management has been dramatic. Only 2 open surgical procedures were required in the first 100 cases, one for a ureteric stricture and the other for a large, longstanding, impacted lower ureteric calculus. Ninety-two patients were treated by ESWL alone. These figures clearly demonstrated the place of ESWL as the backbone of stone therapy.
Professor Eisenberger commented how striking the similarity of these figures was to those of the West German centres. Four cases were presented employing PCN as an alternative treatment when ESWL was inappropriate, due either to anatomical disorders or lucency of the stone. Combined PCN and pyelolysis, cyst aspiration and PCN and ESWL for the treatment of staghorn calculi, including a case of bilateral staghorn caculi, were presented. Intervention by PCN for the removal of retained fragments and decompression of upper tract obstruction was required in 5 cases. Three solitary kidneys developed obstructive anuria and renal failure. These were resolved by PCN, thus confirming the need for the postoperative management to be undertaken by clinicians with percutaneous facilities available. The treatment of upper ureteric calculi by manipulation of the stone endoscopically and subsequent fragmentation by ESWL was demonstrated. The removal of post ESWL stone fragments by URS from the lower ureter was described. It was concluded that a stone centre requires not only a Dornier lithotripter but expertise in renal and ureteric endourology as well as open stone surgery.
Dr M J Kellett commenced the radiological presentation by emphasizing the responsibility of a clinician for the treatment, selection and ongoing care of patients. Management of patients is principally by a urologist. However, there are many situations when a radiologist with training in interventional techniques will be required. Perhaps 5-10% of patients with obstructed kidneys following ESWL may require emergency needle nephrostomy. Patients with pelviureteric junction anomalies or with large staghorn calculi may be better treated by PCN or by a combination of this and ESWL. For optimal management of patients with calculus disease, a lithotripter centre should incorporate facilities for percutaneous renal surgery, and a team of urologist and interventional radiologist serves this best.
Routine ESWL requires pretreatment radiological assessment, including a recent intravenous urogram to confirm free drainage from the kidney. A plain X-ray immediately prior to treatment assesses the stone size and position. A pretreatment ultrasound is used as a baseline, as subsequent obstruction will be shown by dilatation of the collecting system on post-ESWL examination. Monitoring by ultrasound is simple and accurate. Occasionally there can be difficulty in visualizing a stone on the fluoroscopic screen of the lithotripter.
A radiological eye may be a useful addition at these times. Post-treatment ultrasound and plain films assess and monitor the progress of the stone fragments.
In patients who develop obstruction, ultrasound or fluoroscopically guided needle nephrostomies will be required when an obstruction is associated with infection, pain or anuria. Sterile obstruction which is not causing severe symptoms may be followed conservatively, but if this persists a needle nephrostomy is indicated.
Finally, a radiologist is required in the combined treatment of large stones, where a combination of PCN and ESWL are used together.
The integration of a lithotripter service into the National Health Service as a separate 'standalone' facility available on a sessional basis provides unique problems for complicated and emergency clinical situations. These were discussed in detail by Mr R A Miller and form the substance of a separate paper (see p 1034). The Chairman reported that Professor N Blacklock had recently conducted an epidemiological survey from which it had been concluded that about 5 or 6 centralized stone centres would be appropriate for the United Kingdom (Patel et al. 1985) .
The afternoon session involved practical clinical demonstrations of two ESWL procedures at the Devonshire Hospital Lithotripter Centre. These treatments were demonstrated by Mr D R Webb and Mr J E A Wickham, and the procedures were transmitted by closed-circuit television to enable small groups to circulate through the treatment suite for first-hand experience as well as to view the entire proceedings with commentary and open questioning throughout. In closing the proceedings, the Chairman stressed the need for central stone centres for optimal treatment of urolithiasis in the United Kingdom.
